Transdermal

Results: 450



#Item
1NORTH DAKOTA DEPARTMENT OF HEALTH Family Planning Program INFORMATION FOR CONTRACEPTIVE TRANSDERMAL PATCH The contraceptive patch is a thin, flexible square of film that contains both estrogen and progestin. The contrace

NORTH DAKOTA DEPARTMENT OF HEALTH Family Planning Program INFORMATION FOR CONTRACEPTIVE TRANSDERMAL PATCH The contraceptive patch is a thin, flexible square of film that contains both estrogen and progestin. The contrace

Add to Reading List

Source URL: www.ndhealth.gov

Language: English - Date: 2018-05-17 12:25:38
    2Package leaflet: Information for the user EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch norelgestromin/ethinyl estradiol Important things to know about combined hormonal contraceptives (CHCs):

    Package leaflet: Information for the user EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch norelgestromin/ethinyl estradiol Important things to know about combined hormonal contraceptives (CHCs):

    Add to Reading List

    Source URL: www.medicines.org.uk

    Language: English - Date: 2018-08-18 11:10:38
      3NOVEN ANNOUNCES COMMENCEMENT OF PHASE 2 STUDY OF INVESTIGATIONAL d-AMPHETAMINE TRANSDERMAL SYSTEM FOR ADHD October 2, 2012 − Miami, FL and New York, NY − Noven Pharmaceuticals, Inc., a whollyowned subsidiary of Hisam

      NOVEN ANNOUNCES COMMENCEMENT OF PHASE 2 STUDY OF INVESTIGATIONAL d-AMPHETAMINE TRANSDERMAL SYSTEM FOR ADHD October 2, 2012 − Miami, FL and New York, NY − Noven Pharmaceuticals, Inc., a whollyowned subsidiary of Hisam

      Add to Reading List

      Source URL: www.noven.com

      Language: English - Date: 2013-06-27 13:51:08
        4Transdermal Cannabidiol (CBD) Gel for the Treatment of Focal Epilepsy in Adults JOHN MESSENHEIMER, MD1; TERENCE O’BRIEN, MD, FRACP2; SAMUEL F. BERKOVIC, MD, FRACP3; JACQUELINE FRENCH, MD4; MARCEL O. BONN-MILLER, PHD5;

        Transdermal Cannabidiol (CBD) Gel for the Treatment of Focal Epilepsy in Adults JOHN MESSENHEIMER, MD1; TERENCE O’BRIEN, MD, FRACP2; SAMUEL F. BERKOVIC, MD, FRACP3; JACQUELINE FRENCH, MD4; MARCEL O. BONN-MILLER, PHD5;

        Add to Reading List

        Source URL: zynerba.com

        Language: English - Date: 2018-04-25 06:39:12
          5NOVEN PROVIDES UPDATE ON DAYTRANA® METHYLPHENIDATE TRANSDERMAL SYSTEM Shire Undertakes Non-Safety-Related Voluntary Market Withdrawal/Recall of a Limited Portion of Daytrana® Product Financial Reserve Established by No

          NOVEN PROVIDES UPDATE ON DAYTRANA® METHYLPHENIDATE TRANSDERMAL SYSTEM Shire Undertakes Non-Safety-Related Voluntary Market Withdrawal/Recall of a Limited Portion of Daytrana® Product Financial Reserve Established by No

          Add to Reading List

          Source URL: www.noven.com

          Language: English - Date: 2013-06-27 13:50:41
            6A Permeation-Enhanced Synthetic Cannabidiol (CBD) Transdermal Gel for the Treatment of PTSD Marcel O. Bonn-Miller, PhD1 and Donna L. Gutterman, PharmD2 1, University of Pennsylvania Perelman School of Medicine, Philadelp

            A Permeation-Enhanced Synthetic Cannabidiol (CBD) Transdermal Gel for the Treatment of PTSD Marcel O. Bonn-Miller, PhD1 and Donna L. Gutterman, PharmD2 1, University of Pennsylvania Perelman School of Medicine, Philadelp

            Add to Reading List

            Source URL: zynerba.com

            Language: English - Date: 2016-10-24 13:04:29
              7NOVEN TO ACQUIRE DAYTRANA® METHYLPHENIDATE TRANSDERMAL SYSTEM FROM SHIRE The First and Only Patch for ADHD to be Marketed and Sold by Noven Therapeutics Miami, FL, August 10, Noven Pharmaceuticals, Inc. today an

              NOVEN TO ACQUIRE DAYTRANA® METHYLPHENIDATE TRANSDERMAL SYSTEM FROM SHIRE The First and Only Patch for ADHD to be Marketed and Sold by Noven Therapeutics Miami, FL, August 10, Noven Pharmaceuticals, Inc. today an

              Add to Reading List

              Source URL: www.noven.com

              Language: English - Date: 2013-06-27 13:50:54
                8Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle® (Estradiol Transdermal System) Minivelle now approved for prevention of postmenopausal osteoporosis at all doses Newmg/day Minivelle,

                Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle® (Estradiol Transdermal System) Minivelle now approved for prevention of postmenopausal osteoporosis at all doses Newmg/day Minivelle,

                Add to Reading List

                Source URL: www.noven.com

                Language: English - Date: 2014-09-24 14:42:18
                  9May 21, 2018 COMDear provider of pharmaceutical services, Recall: Minivelle™ (estradiol transdermal system) At PharmPix we are committed to the health and well-being of patients. It is for this reason that

                  May 21, 2018 COMDear provider of pharmaceutical services, Recall: Minivelle™ (estradiol transdermal system) At PharmPix we are committed to the health and well-being of patients. It is for this reason that

                  Add to Reading List

                  Source URL: www.pharmpix.com

                  Language: English - Date: 2018-05-24 10:21:33
                    10New Minivelle® (Estradiol Transdermal Systemmg/day Dose Now Available by Prescription in U.S. Pharmacies New dose approved by FDA for the prevention of postmenopausal osteoporosis only; higher doses of Minivelle

                    New Minivelle® (Estradiol Transdermal Systemmg/day Dose Now Available by Prescription in U.S. Pharmacies New dose approved by FDA for the prevention of postmenopausal osteoporosis only; higher doses of Minivelle

                    Add to Reading List

                    Source URL: www.noven.com

                    Language: English - Date: 2015-02-12 09:33:20